Patricia Leonor Musolino, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenoleukodystrophy | 14 | 2024 | 144 | 3.520 |
Why?
|
| Cerebrovascular Disorders | 3 | 2023 | 1478 | 1.100 |
Why?
|
| Blood-Brain Barrier | 4 | 2017 | 1028 | 0.750 |
Why?
|
| Demyelinating Diseases | 2 | 2024 | 354 | 0.610 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 874 | 0.590 |
Why?
|
| Vascular Malformations | 1 | 2023 | 469 | 0.590 |
Why?
|
| Arginine | 2 | 2020 | 932 | 0.580 |
Why?
|
| Stroke | 8 | 2024 | 9744 | 0.560 |
Why?
|
| Thrombectomy | 4 | 2024 | 676 | 0.530 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2017 | 566 | 0.530 |
Why?
|
| Actins | 2 | 2020 | 2061 | 0.510 |
Why?
|
| Microcirculation | 2 | 2017 | 1282 | 0.480 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2024 | 5753 | 0.460 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2014 | 44 | 0.440 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2016 | 180 | 0.410 |
Why?
|
| Microvessels | 1 | 2015 | 586 | 0.370 |
Why?
|
| Sciatic Nerve | 3 | 2009 | 627 | 0.320 |
Why?
|
| Hydrocephalus | 1 | 2016 | 766 | 0.320 |
Why?
|
| Lentivirus | 2 | 2024 | 518 | 0.310 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1023 | 0.300 |
Why?
|
| Disease Progression | 5 | 2021 | 13642 | 0.280 |
Why?
|
| Ganglia, Spinal | 2 | 2007 | 529 | 0.280 |
Why?
|
| Genetic Vectors | 4 | 2024 | 3401 | 0.280 |
Why?
|
| MicroRNAs | 1 | 2023 | 3789 | 0.270 |
Why?
|
| Cerebrovascular Circulation | 2 | 2017 | 2671 | 0.270 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 951 | 0.270 |
Why?
|
| Genetic Variation | 1 | 2020 | 6613 | 0.250 |
Why?
|
| Stromal Cells | 2 | 2009 | 1334 | 0.240 |
Why?
|
| Dependovirus | 2 | 2023 | 720 | 0.230 |
Why?
|
| Child | 19 | 2024 | 80670 | 0.220 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 4424 | 0.210 |
Why?
|
| Brain | 9 | 2024 | 27158 | 0.210 |
Why?
|
| Smad4 Protein | 1 | 2024 | 193 | 0.210 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2023 | 82 | 0.200 |
Why?
|
| RNA, Messenger | 2 | 2015 | 12795 | 0.200 |
Why?
|
| Acetylcysteine | 1 | 2023 | 262 | 0.200 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2023 | 701 | 0.190 |
Why?
|
| Muscle, Smooth | 2 | 2023 | 930 | 0.190 |
Why?
|
| Nerve Degeneration | 2 | 2021 | 748 | 0.180 |
Why?
|
| Capsid | 1 | 2023 | 435 | 0.180 |
Why?
|
| Vision, Low | 1 | 2022 | 162 | 0.170 |
Why?
|
| Neuralgia | 1 | 2007 | 618 | 0.170 |
Why?
|
| Embolectomy | 1 | 2020 | 130 | 0.170 |
Why?
|
| Endovascular Procedures | 3 | 2024 | 2215 | 0.170 |
Why?
|
| Child, Preschool | 11 | 2024 | 42577 | 0.160 |
Why?
|
| Bone Marrow Transplantation | 1 | 2007 | 2730 | 0.160 |
Why?
|
| Neurofilament Proteins | 1 | 2021 | 335 | 0.160 |
Why?
|
| Epilepsies, Partial | 1 | 2022 | 431 | 0.150 |
Why?
|
| Adolescent | 16 | 2024 | 88902 | 0.150 |
Why?
|
| PPAR gamma | 1 | 2021 | 484 | 0.150 |
Why?
|
| Hemizygote | 1 | 2017 | 27 | 0.150 |
Why?
|
| Mydriasis | 1 | 2018 | 13 | 0.150 |
Why?
|
| Sciatic Neuropathy | 3 | 2009 | 76 | 0.150 |
Why?
|
| Transduction, Genetic | 2 | 2023 | 899 | 0.140 |
Why?
|
| Cerebral Revascularization | 1 | 2020 | 260 | 0.140 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2018 | 124 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2023 | 18986 | 0.130 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2018 | 216 | 0.130 |
Why?
|
| Permeability | 1 | 2017 | 721 | 0.130 |
Why?
|
| Young Adult | 7 | 2024 | 59939 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2024 | 36570 | 0.120 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 588 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2017 | 1428 | 0.110 |
Why?
|
| Humans | 31 | 2024 | 766812 | 0.110 |
Why?
|
| Male | 23 | 2024 | 364154 | 0.110 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 692 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2023 | 3408 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2024 | 14473 | 0.100 |
Why?
|
| Recovery of Function | 2 | 2020 | 2978 | 0.100 |
Why?
|
| Infant | 7 | 2024 | 36459 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 1131 | 0.100 |
Why?
|
| Genetic Testing | 2 | 2022 | 3591 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2018 | 708 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1604 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 1080 | 0.090 |
Why?
|
| Fatty Acids | 2 | 2015 | 1806 | 0.090 |
Why?
|
| Homozygote | 1 | 2015 | 1775 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2017 | 22248 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1130 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4570 | 0.090 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 551 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 996 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1969 | 0.080 |
Why?
|
| Constriction, Pathologic | 3 | 2009 | 1104 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1659 | 0.080 |
Why?
|
| Brain Ischemia | 2 | 2020 | 3001 | 0.080 |
Why?
|
| Galanin | 1 | 2009 | 42 | 0.080 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2009 | 47 | 0.080 |
Why?
|
| Phenotype | 2 | 2024 | 16722 | 0.080 |
Why?
|
| Microglia | 1 | 2017 | 1370 | 0.080 |
Why?
|
| Heterozygote | 1 | 2015 | 2795 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4252 | 0.080 |
Why?
|
| Registries | 1 | 2024 | 8352 | 0.080 |
Why?
|
| Stents | 1 | 2020 | 3193 | 0.070 |
Why?
|
| Neuropeptide Y | 1 | 2009 | 194 | 0.070 |
Why?
|
| Levodopa | 1 | 2008 | 221 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 18329 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2021 | 41706 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14762 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2021 | 3582 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2023 | 10451 | 0.070 |
Why?
|
| Apoproteins | 1 | 2006 | 45 | 0.070 |
Why?
|
| Wallerian Degeneration | 1 | 2006 | 68 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2022 | 4747 | 0.070 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2008 | 386 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2015 | 4143 | 0.070 |
Why?
|
| Globins | 1 | 2006 | 405 | 0.060 |
Why?
|
| Female | 15 | 2024 | 396532 | 0.060 |
Why?
|
| Transferrin | 1 | 2006 | 283 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2021 | 81657 | 0.060 |
Why?
|
| Aged | 6 | 2023 | 171344 | 0.060 |
Why?
|
| Adult | 8 | 2024 | 223305 | 0.060 |
Why?
|
| Facies | 1 | 2024 | 224 | 0.050 |
Why?
|
| Clubfoot | 1 | 2024 | 87 | 0.050 |
Why?
|
| Cryptorchidism | 1 | 2024 | 152 | 0.050 |
Why?
|
| Hand Deformities, Congenital | 1 | 2024 | 175 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2009 | 2413 | 0.050 |
Why?
|
| Rats | 6 | 2009 | 23717 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2008 | 8108 | 0.050 |
Why?
|
| Latin America | 1 | 2022 | 416 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2023 | 403 | 0.050 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2006 | 504 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2006 | 796 | 0.050 |
Why?
|
| Fetal Development | 1 | 2006 | 777 | 0.040 |
Why?
|
| Mutation | 3 | 2024 | 30214 | 0.040 |
Why?
|
| Pericytes | 1 | 2023 | 298 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2022 | 376 | 0.040 |
Why?
|
| Cell Movement | 3 | 2007 | 5204 | 0.040 |
Why?
|
| Treatment Outcome | 7 | 2024 | 65286 | 0.040 |
Why?
|
| Intermediate Filaments | 1 | 2021 | 171 | 0.040 |
Why?
|
| Middle Aged | 6 | 2021 | 223267 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 2023 | 468 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2024 | 804 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2024 | 634 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2024 | 820 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2007 | 1865 | 0.040 |
Why?
|
| Fetus | 1 | 2006 | 1878 | 0.040 |
Why?
|
| Axons | 1 | 2006 | 1675 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9613 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2014 | 8065 | 0.040 |
Why?
|
| Lysophosphatidylcholines | 1 | 2017 | 77 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2021 | 539 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2012 | 6597 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2017 | 161 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2022 | 1740 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 3108 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2017 | 656 | 0.030 |
Why?
|
| Animals | 9 | 2024 | 168939 | 0.030 |
Why?
|
| Gadolinium | 1 | 2020 | 964 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 461 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2017 | 633 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2024 | 1403 | 0.030 |
Why?
|
| Neonatal Screening | 1 | 2019 | 619 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 2019 | 751 | 0.030 |
Why?
|
| Insulin | 1 | 2008 | 6608 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 4401 | 0.030 |
Why?
|
| Brain Stem | 1 | 2019 | 858 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 59548 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1337 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2015 | 258 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 772 | 0.030 |
Why?
|
| Gene Expression | 2 | 2017 | 7585 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1617 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3343 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2006 | 1887 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 2127 | 0.030 |
Why?
|
| Medical Records | 1 | 2018 | 1408 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2017 | 1526 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2024 | 26387 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 1417 | 0.020 |
Why?
|
| Massachusetts | 1 | 2024 | 8890 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 2654 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1525 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2020 | 1949 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2008 | 5022 | 0.020 |
Why?
|
| Genotype | 1 | 2024 | 13036 | 0.020 |
Why?
|
| Antibodies | 1 | 2017 | 2421 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 11062 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2017 | 1811 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 1944 | 0.020 |
Why?
|
| Neuroglia | 1 | 2015 | 960 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5306 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2019 | 2858 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6066 | 0.020 |
Why?
|
| Nuclease Protection Assays | 1 | 2006 | 14 | 0.020 |
Why?
|
| Contrast Media | 1 | 2020 | 5329 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3702 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2022 | 6282 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 874 | 0.020 |
Why?
|
| Trypsin | 1 | 2006 | 490 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 22351 | 0.020 |
Why?
|
| Axonal Transport | 1 | 2006 | 178 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2006 | 195 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8540 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2006 | 240 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 23618 | 0.020 |
Why?
|
| Colchicine | 1 | 2006 | 257 | 0.020 |
Why?
|
| Aging | 2 | 2019 | 8728 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 505 | 0.010 |
Why?
|
| Nervous System Malformations | 1 | 2006 | 243 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 1729 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3360 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2015 | 4166 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 498 | 0.010 |
Why?
|
| Mice | 2 | 2024 | 81898 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18397 | 0.010 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 456 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15835 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 39312 | 0.010 |
Why?
|
| Tubulin | 1 | 2006 | 694 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 2006 | 490 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 2006 | 650 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2008 | 1610 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2006 | 1179 | 0.010 |
Why?
|
| Microtubules | 1 | 2006 | 1063 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1600 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 54872 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 956 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4914 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40149 | 0.010 |
Why?
|
| Neurons | 1 | 2017 | 9515 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 17089 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3723 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 8310 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2008 | 3698 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29959 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 2513 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 18076 | 0.010 |
Why?
|
| Risk Factors | 1 | 2022 | 74889 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 4347 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10745 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 5753 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 15425 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 30236 | 0.000 |
Why?
|